GLP-1 RA Therapy for IBD: Weight Loss and Clinical Outcomes
GLP-1 receptor agonist inflammatory bowel disease therapy offers promising weight loss and metabolic improvements. This approach combines pharmacotherapy with lifestyle changes for better clinical outcomes. Patients with IBD may benefit from this…
GLP-1 Weight Loss Cardiovascular Evidence: Meta-Analysis Review
Intragastric balloon therapy obesity is a meaningful treatment option for patients not ready for surgery or pharmacotherapy. This therapy offers short-term weight reduction comparable to semaglutide 2.4 mg weekly. Understanding this evidence helps…
CBD Gummies and IBS: What the Evidence Shows and How to Approach Them
The cbd gummies ibs evidence highlights emerging research on cannabidiol's role in managing irritable bowel syndrome symptoms. While preclinical studies suggest potential benefits, clinical data remain limited. Patients should approach CBD use cautiously…
Why Some Cannabis Users Get CHS — And Most Don’t with Codi Peterson
Cannabinoid hyperemesis syndrome clinical relevance is critical for understanding why some cannabis users develop CHS while most do not. This syndrome causes severe cyclic vomiting and requires complete cannabis cessation for resolution. Awareness of CHS…
New Research on Cannabinoid Hyperemesis Syndrome (CHS) with Dr. Codi Peterson
Cannabinoid hyperemesis syndrome clinical insights reveal key symptoms and management strategies for chronic cannabis users. This syndrome involves severe nausea and vomiting relieved by hot water. Understanding CHS is crucial for accurate diagnosis and…
![[Management of cannabinoid hyperemesis syndrome].](https://cedclinic.com/wp-content/uploads/2026/04/tmpogv1rfsb.jpg "[Management of cannabinoid hyperemesis syndrome].")
[Management of cannabinoid hyperemesis syndrome].
Cannabinoid hyperemesis syndrome (CHS) is a condition that affects approximately one-third of cannabis users. Symptoms include recurrent episodes of vomiting...
Heavy Use of Vape Cartridges Linked to Cannabis Hyperemesis Syndrome, New Study Finds
Cannabis hyperemesis syndrome vaping is linked to severe nausea and vomiting in chronic users. Heavy use of vape cartridges may increase the risk of this syndrome. Understanding this connection helps clinicians guide patient care effectively.
Clinical Insights on Preoperative Magnetic Resonance Cholangiopancreatography
Preoperative magnetic resonance cholangiopancreatography is valuable for predicting the success of endoscopic stone removal. This imaging technique aids clinical decision-making in gastroenterology. Understanding its application enhances patient care…
Predictive Clinical Factors for Endoscopic Ultrasound Diagnosis in Undiagnosed Common …
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic GastroenterologyDiagnosticsNon-Cannabis Why…
SAFE GC Coalition: Cannabis Hyperemesis Syndrome on the Rise in Glen Cove
Cannabis hyperemesis syndrome increasing is a critical clinical concern linked to chronic cannabis use. This syndrome causes severe cyclical vomiting often misdiagnosed in emergency settings. Awareness of cannabis hyperemesis syndrome increasing is…